1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. (2012) HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European heart rhythm association (EHRA), a registered branch of the European society of cardiology (ESC) and the European cardiac arrhythmia society (ECAS); and in collaboration with the American college of cardiology (ACC), American heart association (AHA), the Asia pacific heart rhythm society (APHRS), and the society of thoracic surgeons (STS). Endorsed by the governing bodies of the American college of cardiology foundation, the American heart association, the European cardiac arrhythmia society, the European heart rhythm association, the society of thoracic surgeons, the Asia pacific heart rhythm society, and the heart rhythm society. Heart Rhythm;9(4):632–696 e21
2. Nault I, Miyazaki S, Forclaz A, Wright M, Jadidi A, Jais P et al (2010) Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation. Eur Heart J 31(9):1046–1054
3. Arya A, Hindricks G, Sommer P, Huo Y, Bollmann A, Gaspar T et al (2010) Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace 12(2):173–180
4. Machino-Ohtsuka T, Seo Y, Tada H, Ishizu T, Machino T, Yamasaki H et al (2011) Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol 22(9):999–1006
5. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): a randomised controlled trial. Lancet 376(9756):1903–1909